|
TMEM106B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.567200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.024000E-01 |
| Normal-vs-Stage2 |
5.998800E-01 |
| Normal-vs-Stage3 |
4.677000E-01 |
| Normal-vs-Stage4 |
3.110600E-01 |
| Stage1-vs-Stage2 |
9.995600E-01 |
| Stage1-vs-Stage3 |
8.401800E-01 |
| Stage1-vs-Stage4 |
5.630200E-01 |
| Stage2-vs-Stage3 |
8.962800E-01 |
| Stage2-vs-Stage4 |
6.609000E-01 |
| Stage3-vs-Stage4 |
7.149800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.172000E-01 |
| Normal-vs-AfricanAmerican |
8.985200E-01 |
| Normal-vs-Asian |
1.390220E-01 |
| Caucasian-vs-AfricanAmerican |
4.821400E-01 |
| Caucasian-vs-Asian |
3.326400E-01 |
| AfricanAmerican-vs-Asian |
2.054000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.244400E-01 |
| Normal-vs-Female |
6.047200E-01 |
| Male-vs-Female |
2.714800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.373200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.349600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.361400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.676000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.666000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.360400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.096800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.680400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.040000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.745600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.781000E-01 |
| Classical-VS-Follicular |
2.250600E-01 |
| Classical-VS-Other |
2.357400E-01 |
| Classical-VS-Normal |
7.882200E-01 |
| Tall-VS-Follicular |
3.274800E-01 |
| Tall-VS-Other |
1.712250E-01 |
| Tall-VS-Normal |
9.511600E-01 |
| Follicular-VS-Other |
4.417200E-01 |
| Follicular-VS-Normal |
2.711000E-01 |
| Other-VS-Normal |
1.675230E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.099200E-01 |
| Normal-vs-N1 |
2.444000E-01 |
| N0-vs-N1 |
7.053200E-01 |
|
|
